Role of connexin 43 in cardiovascular diseases

Eur J Pharmacol. 2015 Dec 5:768:71-6. doi: 10.1016/j.ejphar.2015.10.030. Epub 2015 Oct 20.

Abstract

Gap junctions (GJs) channels provide the basis for intercellular communication in the cardiovascular system for maintenance of the normal cardiac rhythm, regulation of vascular tone and endothelial function as well as metabolic interchange between the cells. They allow the transfer of small molecules and may enable slow calcium wave spreading, transfer of "death" or of "survival" signals. In the cardiomyocytes the most abundant isoform is Connexin 43 (Cx43). Alterations in Cx43 expression and distribution were observed in myocardium disease; i.e. in hypertrophic cardiomyopathy, heart failure and ischemia. Recent reports suggest the presence of Cx43 in the mitochondria as well, at least in the inner mitochondrial membrane, where it plays a central role in ischemic preconditioning. In this review, the current knowledge on the relationship between the remodeling of cardiac gap junctions and cardiac diseases are summarized.

Keywords: AAP10; Cardiovascular disease; Connexin 43; DIAZOXIDE; GAP-134; GAP-26; GAP-27; GELDANAMYCIN; Gap junction; HEPTANOL; Mitochondria; RADICICOL; RXP-E; ZP123.

Publication types

  • Review

MeSH terms

  • Animals
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / metabolism*
  • Connexin 43 / antagonists & inhibitors
  • Connexin 43 / metabolism*
  • Humans

Substances

  • Connexin 43